Leptomeningeal metastasis in the era of CNS-penetrant tyrosine kinase inhibitor therapy Editorial

  

Authors:	Jeng, M. Y.; Yu, H. A.
Title:	Leptomeningeal metastasis in the era of CNS-penetrant tyrosine kinase inhibitor therapy
Keywords:	middle aged; treatment failure; case report; nuclear magnetic resonance imaging; clinical practice; quality of life; protein kinase inhibitor; editorial; practice guideline; protein tyrosine kinase; tyrosine kinase inhibitors; protein tyrosine kinase inhibitor; protein kinase inhibitors; meningeal neoplasms; cancer cell; cell isolation; protein-tyrosine kinases; drug therapy; cell invasion; carcinomatous meningitis; neurologic examination; circulating tumor cell; cerebrospinal fluid cytology; central nervous system metastasis; meningeal carcinomatosis; humans; human; male; female; osimertinib; erbium; amivantamab; meningeal tumor; lazertinib
Journal Title:	Journal of Clinical Oncology
Volume:	42
Issue:	23
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2024-08-10
Start Page:	2727
End Page:	2730
Language:	English
DOI:	10.1200/jco.24.01061
PUBMED:	38941569
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85201029572&doi=10.1200%2fJCO.24.01061&partnerID=40&md5=5fb6f71a8e1d8f342baea8fa3a5e30e3
Notes:	Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/218128